Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

"There probably won't be a single magic solution for Alzheimer's disease. In the case of cancer and HIV ... For now, the ...

Chronic obstructive pulmonary disease (COPD) burden remains high in underdeveloped regions of China despite a decline in ...

Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

China - Robots, AI products widely applied to life, production scenarios in China (Voice_over) Highly developed products like ...

Leqembi’s sales continue to be underwhelming, according to analysts, who contend the companies’ Alzheimer’s disease therapy ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

China remains a core market for Edwards Lifesciences, especially with the ongoing improvements in the country's business ...

“FTD tends do occur at a younger age than does Alzheimer’s disease. It often begins between the ages of ... Kevin Mwenda, a ...

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

Biogen raised its full-year guidance and now expects adjusted EPS to range from $16.10 to $16.60, up from prior guidance of $15.75 to $16.25. It still expects revenue to fall by a low-single-digit ...